20.04.2023 13:26:59

EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: PharmaSGP Holding SE / Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

20.04.2023 / 13:26 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: April 27, 2023
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 27, 2023
Address: https://ir.pharmasgp.com/en/#FinancialReports

Report Type: Annual financial report of the group

Language: German
Date of disclosure: April 27, 2023
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 27, 2023
Address: https://ir.pharmasgp.com/en/#FinancialReports


20.04.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 1
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com

 
End of News EQS News Service

1610349  20.04.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1610349&application_name=news&site_id=smarthouse

Analysen zu PharmaSGPmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PharmaSGP 25,60 0,79% PharmaSGP